Genetic Polymorphisms of p53 Tumor Suppressor Gene in Korean Population

Korean Journal of Genetics

Volumn 23, Issue 3, 2001, Pages 227-232

  Hwang, Hye Suk ^a   Hwang, Jung Hee ^a   Shin, Sang Hee ^a   Kim, Hyun Sup ^a   Kim, Nam Keun ^b   Kim, Se Jae ^c   Chung, Ki Wha ^a  

^a Kongju National University   (South Korea)

^b CHA University   (South Korea)

^c Jeju National University   (South Korea)

Author keywords

And Restriction fragment length polymorphism; Cervical cancer; p53

Indexed keywords

EID: 0035637881     PISSN: 02545934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Beckman G, Birgander R, Själander A, Saha N, Holmberg PA, Kivelä A and Beckman L (1994) Is p53 polymorphism maintained by natural selection. Hum. Genet. 44: 266-270.
2. Carbone D, Chiba I and Mitsudomi T (1991) Polymorphism at codon 213 within the p53 gene. Oncogene 6: 1691-1692.
3. Chung KW, Hwang JH, Hwang HS, Kim HS and Lee CC (1998) Genetic variation at the YNZ22 (D17S5) Variable number of tandem repeat (VNTR) locus in Korean population. Korean J. Genetics 20: 83-90.
4. Felix CA, Brown DL, Mitsudomi T, Ikegaki N, Wong A, Wasserman R, Womer RB and Biegel JA (1994) Polymorphism at codon 36 of the p53 gene. Oncogene 9: 327-328.
5. Hollstein M, Sidransky D, Vogelstein B and Harris CC (1991) p53 mutations in human cancers. Science 253: 49-53.
6. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R and Harris CC (1994) Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22: 3551-3555.
7. Ito T, Seyama T, Hayashi T, Mizuno T, Iwamoto KS, Tsuyama N, Dobi K, Nakamura N and Akiyama M (1994) Hae III polymorphism in intron 1 of the human p53 gene. Hum. Genet. 93: 222.
8. Kawajiri K, Nakachi K, Imai K, Watanabe J and Hayashi SI (1993) Germ line polymorphism of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 14: 1085-1089.
9. Kim HS, Chung KW and Park KS (1999) Polymorphisms of apolipoprotein E and H in Korean population: confirming the distribution of APOH*3Kongju allele. Korean J. Genetics 21: 89-95.
10. Kim JW, Lee CG, Han SM, Kim KS, Kim JO, Lee JM, Kim IK and Namkoong SE (1997) Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection. Gynecol. Oncol. 67: 215-221.
11. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
12. McDaniel T, Carbone D, Takahashi T, Chumakov P, Chang EH, Pirollo KF, Yin J, Huang Y and Meltzer SJ (1991) The MspI polymorphism in intron 6 of p53 (TP53) detected by digestion of PCR products. Nucleic Acids Res. 19: 4796.
13. Rosenthal AN, Ryan A, Al-Jehani RM, Storey A, Harwood CA and Jacobs IJ (1998) p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet 352: 871-872.
14. Sanger F, Nicklen S and Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U.S.A. 74: 5463-5467.
15. Shoshana P, Yulia K, Sam S, Arel H, Katia K and Varda R (1995) A novel polymorphism in intron 6 of the human p53 gene: a possible association with cancer predisposition and susceptibility. DNA and Cell Biol. 14: 983-990.
16. Själander A, Birgander R, Kivelä A and Beckman G (1995) p53 polymorphisms and haplotypes indifferent ethnic groups. Hum. Hered. 45: 144-149.
17. Själander A, Birgander R, Saha N, Beckman L and Beckman G (1996) p53 polymorphisms and haplotypes show distinct differences between major ethnic groups. Hum. Hered. 46: 41-48.
18. Weston A, Perrin LS, Forrester K, Hoover RN, Trump BF, Harris CC and Caporaso NE (1992) Allelic frequency of a p53 polymorphism in human lung cancer. Cancer Epidemiol. Biomarkers Prev. 1: 481-483.
19. Young LS, Bevan IS, Johnson MA, Blomfield PI, Bromidge T, Maitland NJ and Woodman CBJ (1989) The polymerase chain reaction: a new epidemiologic tool for investigating cervical human papillomavirus infection. Br. Med. J. 298: 14-18.